Chemistree Technology Inc. (CSE:CHM; OTC:CHMJF) has launched its campaign on the Investing News Network’s cannabis channel.

Chemistree Technology is building a portfolio of vertically-integrated cannabis assets across North America. By leveraging an elite team of cannabis veterans, Chemistree is building a multi-state network of cannabis operations in cultivation, processing, distribution and retail. Chemistree owns the operational assets and national branding rights to Sugarleaf, a Washington-based cannabis brand. Sugarleaf’s premium cannabis products are available in dispensaries across the state.


In addition to its Washington operations, Chemistree has begun expansion into California’s emerging cannabis market as well. The company has been granted a Conditional Use Permit (CUP) by the city of Desert Hot Springs, which Chemistree will use to develop its 9.55-acre property in California’s cannabis cultivation zone. Chemistree intends to continue to develop its Sugarleaf brand with distribution throughout the state of California in the future.

Chemistree Technology’s company highlights include the following:

  • Vertically-integrated company expanding into premiere cannabis jurisdictions in the US and beyond.
  • Team of true cannabis entrepreneurs with decades of experience in managing all aspects of profitable cannabis businesses including branding, cultivation, manufacturing and finance.
  • Strong foothold in Washington State, a market with nearly 750,000 recreational cannabis consumers.
  • Immediate access to one of the world’s biggest cannabis markets via California Processor’s License for Sugarleaf-branded products.
  • Granted CUP license at 9.55-acre Desert Hot Springs property.
  • Plans in 2019 to increase cultivation yield at Sugarleaf facility, expand retail footprint, product offerings and develop Desert Hot Springs greenhouse cultivation facility.
  • Well-financed with $10,830,000 capital raise completed in March 2019.
  • Tight share structure with management and consultants holding 50 percent of shares, representing more than $2 million in insider investment.

Click here to see the educational profile for Chemistree Technology Inc. (CSE:CHM; OTC:CHMJF) and to request an investor presentation.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.

The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.

Keep reading... Show less

HempFusion Wellness Inc. ( TSX:CBD.U ) ( FWB:8OO ) (“ HempFusion ” or the “ Company ”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ ETFs ”), AdvisorShares Pure US Cannabis ETF ( NYSE:MSOS ) and AdvisorShares Pure Cannabis ETF ( NYSE:YOLO ).

AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“ AUM ”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.

Keep reading... Show less